Abstract
The development of metal-based anticancer drugs has been hampered, among other reasons, by their lack of selectivity for cancer cells. In a recent article, Zou and co-workers presented the successful intracellular activation of organogold(I) complexes for potential cancer treatment through Pd(II)-mediated transmetallation, overcoming some off-target activity of novel gold-based drugs. This unique strategy builds the perfect bridge between metallodrug usage and bioorthogonal intracellular catalysis for more advanced and selective therapies. Such an approach will hopefully pave the way for forthcoming studies in medicinal inorganic chemistry.
Keywords:
anticancer drugs; gold; intracellular catalysis; palladium; transmetallation.
© 2021 Wiley-VCH GmbH.
Publication types
-
Research Support, Non-U.S. Gov't
-
Review
MeSH terms
-
Antineoplastic Agents / chemistry*
-
Antineoplastic Agents / therapeutic use
-
Coordination Complexes / chemistry*
-
Coordination Complexes / therapeutic use
-
Gold / chemistry
-
Humans
-
Neoplasms / drug therapy
-
Neoplasms / pathology
-
Palladium / chemistry
-
Transition Elements / chemistry*
Substances
-
Antineoplastic Agents
-
Coordination Complexes
-
Transition Elements
-
Palladium
-
Gold
Grants and funding
-
SFRH/BD/132710/2017/Fundação para a Ciência e a Tecnologia, Ministério da Ciência e da Tecnologia, Portugal
-
UIDB/04138/2020/Fundação para a Ciência e a Tecnologia, Ministério da Ciência e da Tecnologia, Portugal
-
UIDP/04138/2020/Fundação para a Ciência e a Tecnologia, Ministério da Ciência e da Tecnologia, Portugal
-
PTDC/QUI-QOR/29967/2017/Fundação para a Ciência e a Tecnologia, Ministério da Ciência e da Tecnologia, Portugal
-
LISBOA-01-0145-FEDER-029967/Fundação para a Ciência e a Tecnologia, Ministério da Ciência e da Tecnologia, Portugal
-
GA 681679/ERC Consolidator Grant PhotoMedMet
-
"Investissements d'Avenir"
-
French Government
-
ANR-10-IDEX-0001-02 PSL/ANR